---
figid: PMC6697704__41540_2019_107_Fig1_HTML
figlink: /pmc/articles/PMC6697704/figure/Fig1/
number: F1
caption: Diagram of the main molecular interactions implemented in the model. The
  diagram illustrates surface molecules and their interactions (on the left), as well
  as the intracellular downstream signaling to ERK (extracellular-regulated kinase)
  and Akt (on the right). Surface Met can bind hepatocyte growth factor (HGF) and
  get activated in the absence of α5β1 integrin that leads to rapid internalization
  and degradation, whereas integrin-bound Met has lower internalization/degradation
  and higher recycling rates. In addition to integrin-binding peptide (AXT050) that
  dissociates the Met/α5β1 complex, effect of anti-Met (cabozantinib), anti-HGF (rilotumumab),
  and Raf inhibitor (sorafenib) drugs were explored in this study
pmcid: PMC6697704
papertitle: Mechanistically detailed systems biology modeling of the HGF/Met pathway
  in hepatocellular carcinoma.
reftext: Mohammad Jafarnejad, et al. NPJ Syst Biol Appl. 2019;5:29.
pmc_ranked_result_index: '157395'
pathway_score: 0.6685765
filename: 41540_2019_107_Fig1_HTML.jpg
figtitle: Main molecular interactions implemented in the model
year: '2019'
organisms: Homo sapiens
ndex: 1a52e888-deb1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6697704__41540_2019_107_Fig1_HTML.html
  '@type': Dataset
  description: Diagram of the main molecular interactions implemented in the model.
    The diagram illustrates surface molecules and their interactions (on the left),
    as well as the intracellular downstream signaling to ERK (extracellular-regulated
    kinase) and Akt (on the right). Surface Met can bind hepatocyte growth factor
    (HGF) and get activated in the absence of α5β1 integrin that leads to rapid internalization
    and degradation, whereas integrin-bound Met has lower internalization/degradation
    and higher recycling rates. In addition to integrin-binding peptide (AXT050) that
    dissociates the Met/α5β1 complex, effect of anti-Met (cabozantinib), anti-HGF
    (rilotumumab), and Raf inhibitor (sorafenib) drugs were explored in this study
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT16
  - WNT4
  - WNT1
  - WNT2
  - WNT3
  - WNT5A
  - WNT6
  - WNT7A
  - WNT7B
  - WNT2B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT5B
  - WNT3A
  - PAK5
  - PDK1
  - RHOG
  - WNT8A
  - RPS6KA5
  - SOS1
  - SOS2
  - RAF1
  - BRAF
  - HRAS
  - KRAS
  - NRAS
  - RPS6KA6
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KB1
  - RPS6KB2
  - RPS6KA4
  - WNT10B
  - WNT11
  - SLTM
  - PAK4
  - PAK1
  - PAK2
  - PAK3
  - AKT3
  - AKT1
  - AKT2
  - MAPK1
  - MAPK3
  - WNT8B
  - RAC2
  - RAC3
  - ARAF
  - MAP2K2
  - RAC1
  - GAB1
  - HGF
  - PAK6
  - MAP2K1
  - Met
  - Cabozantinib
  - Sorafenib
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK5
  entrez: '57144'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK4
  entrez: '10298'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK2
  entrez: '5062'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK3
  entrez: '5063'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Gab1
  symbol: GAB1
  source: hgnc_symbol
  hgnc_symbol: GAB1
  entrez: '2549'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK6
  entrez: '56924'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals:
- word: Met
  source: MESH
  identifier: C034758
- word: Cabozantinib
  source: MESH
  identifier: C558660
- word: Sorafenib
  source: MESH
  identifier: C471405
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6697704__F1
redirect_from: /figures/PMC6697704__F1
figtype: Figure
---
